Results 201 to 210 of about 371,531 (327)
High-Risk Neuroblastoma Stage 4 (NBS4): Developing a Medicinal Chemistry Multi-Target Drug Approach. [PDF]
MoleculesGerges A, Canning U.
europepmc +1 more source
Medicinal Chemistry: Defining Itself [PDF]
, 2008 Rainer Metternich, Giorgio Tarzia
openalex +1 more source
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source
Revolutionizing Playing with Skeleton Atoms: Molecular Editing Surgery in Medicinal Chemistry. [PDF]
Mini Rev Med ChemRabie AM.
europepmc +1 more source
Molecular Oncology, EarlyView.Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source